Plx pharma inc. (PLXP)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
REVENUES:
Total revenues

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Federal grants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

-

-

829

1,004

-

-

805

651

860

778

438

375

20

20

0

0

0

-

-

-

-

-

0

-

-

-

-

-

-

OPERATING EXPENSES:
Research and development

4,262

4,741

4,695

4,700

3,836

3,922

5,476

5,216

5,108

4,157

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and Development Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,160

11,286

9,416

8,488

8,790

8,898

7,875

5,982

3,423

1,729

0

0

0

General and administrative

10,275

10,026

9,101

8,398

7,795

7,791

7,782

9,003

11,197

10,174

8,275

6,295

3,721

4,752

6,423

6,953

7,247

7,478

7,109

6,852

6,435

4,684

4,685

3,725

2,727

2,284

0

0

0

TOTAL OPERATING EXPENSES

14,538

14,767

13,797

13,099

11,632

11,714

15,553

16,514

18,600

16,626

6,458

3,532

345

4,830

13,862

17,837

20,407

18,764

16,525

15,340

15,226

13,582

12,561

9,708

6,150

4,013

0

0

0

OPERATING LOSS

-14,287

-14,202

-12,968

-12,094

-10,642

-10,961

-14,747

-15,862

-17,740

-15,847

-6,020

-3,156

-325

-4,810

-13,842

-17,817

-20,407

-18,764

-16,525

-15,340

-15,226

-13,582

-12,561

-9,708

-6,150

-4,013

0

0

0

OTHER INCOME (EXPENSE):
Interest Income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35

22

0

0

0

-

-

-

-

-

-

-

-

Interest income

370

405

407

373

313

297

283

239

179

112

0

0

0

-

0

0

-

-

-

-

-

-

0

0

-

-

-

-

-

Interest and other expense

845

994

1,101

1,162

1,165

1,145

1,122

1,000

1,358

1,164

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-6,615

5,710

1,893

7,801

3,445

-12,705

-5,652

-6,313

-9,058

-633

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL OTHER INCOME (EXPENSE)

6,140

-6,300

-2,587

-8,590

-4,297

11,857

4,813

5,553

7,878

-418

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

INCOME (LOSS) BEFORE INCOME TAXES

-8,147

-20,502

-15,555

-20,684

-14,940

896

-9,934

-10,308

-9,861

-16,266

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes

-

-

-

-

-

-

-

-

-

-920

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCOME (LOSS)

-8,147

-20,502

-15,555

-20,684

-14,940

896

-9,934

-10,308

-8,941

-15,346

-4,000

-1,283

-515

-4,905

-13,871

-17,808

-20,372

-18,742

-16,512

-15,336

-15,224

-13,580

-12,559

-9,707

-6,150

-4,013

0

0

0

Preferred dividends and beneficial conversion feature

1,250

13,750

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS

-

-

-

0

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share - basic (in dollars per share)

0.08

-0.12

0.09

-1.10

-2.71

0.33

-0.39

-0.41

0.57

-1.06

-0.44

-0.36

-0.33

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share - diluted (in dollars per share)

0.08

-0.12

0.09

-1.10

-2.71

0.33

-0.39

-0.41

0.57

-1.06

-0.44

-0.36

-0.33

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares of common shares - basic (in shares)

9,156

9,212

8,921

8,779

8,750

8,742

8,735

8,729

8,725

8,835

8,704

6,157

4,383

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares of common shares - diluted (in shares)

9,216

9,198

8,936

8,779

8,750

8,742

8,735

8,729

8,725

8,835

8,704

6,157

4,383

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per common share - basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

0.02

-0.25

-0.33

-0.56

-0.54

-0.49

-0.47

-0.49

-0.38

-0.45

-0.46

-0.44

-0.67

-0.21

-0.08

0.09

Weighted average common shares outstanding - basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,548

4,383

4,383

10,315

10,319

10,274

8,584

8,552

8,576

8,537

8,537

5,749

4,922

4,771

4,429

4,370

Grant [Member]
Total revenues

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

-

-

829

1,004

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-